Updates

24. 11. 2023

FSA slashes daily CBD intake guidance: UK industry reacts

The Food Standards Agency and Food Standards Scotland have updated their advice on the Acceptable Daily Intake (ADI) for cannabidiol in a move that has alarmed the CBD industry. In February 2020, the FSA published advice on CBD consumption for the first time. This guidance explained that consumers should not exceed 70mg of CBD in a 24-hour period. However, this week has seen a dramatic reduction in that number, slashed to 10mg per day for healthy adults, highlighting potential long-term side effects.

03. 11. 2023

Medical Cannabis Awareness Week: The Patient Conference with Drug Science

This November marks the third year of celebrating Medical Cannabis Awareness Week - a whole week dedicated to highlighting the successes of the medical cannabis industry but also provides an opportunity to bring together all sectors for reflection and discussions. Drug Science, leaders of the T21 medical cannabis patient study are hosting The Patient Conference with The Medcan Family Foundation on November 3rd at Conway Hall in London. Tickets are available here.

01. 11. 2023

National stress day: Exploring stress management with medical cannabis

The 1st of November 2023 is an important day for many in the medical cannabis community, because it marks five years of its legalisation in the UK. But, what you may not have known is that November the 1st is also the day dedicated to raising awareness of stress – a condition medical cannabis has shown potential in alleviating.

04. 07. 2023

Release of the Releaf "Say No To Pain Report"

Here at Releaf, we are thrilled to announce the release of our first market research report that investigates the awareness and prevalence of medical cannabis in the UK, and analyses the public perceptions and societal stigmas that surround this powerful plant.